Schenkein David P - Insider Non-Derivative Transactions at Denali Therapeutics Inc. (DNLI) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 31, 2024, Schenkein David P's relationship to Denali Therapeutics Inc. (DNLI) is Director, and currently has 21,496 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DNLI insiders.
Data Source: SEC.
Schenkein David P - Insider Non-Derivative Transactions of DNLI Common Stock
Schenkein David P - Insider Non-Derivative Transactions at DNLI
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 1, 2024 | Acquisition -- (Common Stock) | 5967 | 0 | 21496 |
| Jun 2, 2023 | Acquisition -- (Common Stock) | 4216 | 0 | 15529 |